Mithra Pharmaceuticals SA
Mithra Pharmaceuticals SA, a leading biopharmaceutical company headquartered in Belgium, is renowned for its innovative approach to women's health. Founded in 1999, Mithra has established a strong presence in Europe and beyond, focusing on the development of contraceptive solutions and hormone therapies. The company’s flagship products, including the unique contraceptive pill Estelle and the innovative hormone replacement therapy, are designed to meet the specific needs of women, setting Mithra apart in a competitive market. With a commitment to research and development, Mithra has achieved significant milestones, positioning itself as a key player in the women's health sector. Recognised for its dedication to quality and innovation, Mithra Pharmaceuticals continues to expand its portfolio, striving to improve the lives of women globally through effective and safe healthcare solutions.
DitchCarbon Score
How does Mithra Pharmaceuticals SA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Mithra Pharmaceuticals SA's score of 16 is higher than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Mithra Pharmaceuticals SA's reported carbon emissions
Mithra Pharmaceuticals SA, headquartered in Belgium, currently does not have available data on carbon emissions, as no specific emissions figures have been provided. Consequently, there are no reported Scope 1, 2, or 3 emissions data to analyse. Additionally, the company has not outlined any formal reduction targets or climate commitments, nor does it appear to have made any pledges related to climate action. In the absence of specific emissions data or commitments, it is unclear how Mithra Pharmaceuticals is addressing its carbon footprint or contributing to broader sustainability efforts within the pharmaceutical industry.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Mithra Pharmaceuticals SA is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
